| Literature DB >> 28591341 |
Jun Wang1, Xuejun Wang2, Zhen Fang2, Nanjia Lu3, Liyuan Han3.
Abstract
OBJECTIVE: : We aimed to analyze the applicability of a fracture risk assessment tool for the prediction of osteoporotic fractures in middle-aged and elderly healthy Chinese adults.Entities:
Mesh:
Year: 2017 PMID: 28591341 PMCID: PMC5439115 DOI: 10.6061/clinics/2017(05)06
Source DB: PubMed Journal: Clinics (Sao Paulo) ISSN: 1807-5932 Impact factor: 2.365
Basic characteristics and FRAX-based 10-year osteoporotic fracture probabilities.
| Total | Males | Females | χ2 or t | P | |
|---|---|---|---|---|---|
| Age | 63.18±8.93 | 66.31±8.38 | 62.49±8.91 | 3.514 | <0.001 |
| BMI | 23.72±3.15 | 24.60±3.23 | 23.53±3.10 | 2.783 | 0.006 |
| BMI<18.5 | 21 (4.73%) | 4 (5.00%) | 17 (4.67%) | 0.015 | 0.904 |
| Prior fracture | 99 (22.30%) | 20 (25.00%) | 79 (21.70%) | 0.857 | 0.602 |
| Parental history of fracture | 46 (10.36%) | 8 (10.00%) | 38 (10.44%) | 0.014 | 0.907 |
| Current smoking | 19 (4.28%) | 16 (20.00%) | 3 (0.82%) | 54.288 | <0.001 |
| Current alcohol consumption | 46 (10.36%) | 29 (36.25%) | 17 (4.67%) | 70.429 | <0.001 |
| History of steroid use | 11 (2.48%) | 2 (2.50%) | 9 (2.47%) | <0.001 | 0.989 |
| Rheumatoid arthritis | 21 (4.73%) | 1 (1.25%) | 20 (5.49%) | 1.765 | 0.184 |
| Secondary osteoporosis | 34 (7.66%) | 1 (1.25%) | 33 (9.07%) | 5.666 | 0.017 |
| Osteoporosis | 175 (39.59%) | 19 (24.05%) | 156 (42.98%) | 9.725 | 0.008 |
| Osteopenia | 208 (47.06%) | 47 (59.49%) | 161 (44.35%) | ||
| MOFP | 4.93±3.30 | 3.41±1.77 | 5.26±3.46 | 6.859 | <0.001 |
| HOFP | 1.64±1.90 | 1.32±1.25 | 1.71±2.01 | 2.227 | 0.027 |
| MOFP | 4.97±3.53 | 3.75±2.17 | 5.24±3.71 | 4.746 | <0.001 |
| HOFP | 1.54±2.21 | 1.53±1.64 | 1.55±2.32 | 0.093 | 0.926 |
BMI: body mass index;
MOFP: the FRAX-based 10-year major osteoporotic fracture probability;
BMD: bone mineral density;
HOFP: the FRAX-based 10-year hip osteoporotic fracture probability.
FRAX-based 10-year osteoporotic fracture probabilities among subjects in different age groups.
| Age (years) | N | Without BMD | With BMD | ||
|---|---|---|---|---|---|
| Major fracture | Hip fracture | Major fracture | Hip fracture | ||
| <50 | 22 | 1.78±0.74 | 0.20±0.18 | 1.90±0.48 | 0.28±0.26 |
| 50-59 | 133 | 3.37±2.13 | 0.58±0.60 | 3.59±2.12 | 0.67±0.79 |
| 60-69 | 191 | 5.32±3.20 | 1.61±1.69 | 5.44±3.80 | 1.55±2.44 |
| 70-79 | 79 | 6.40±3.41 | 3.08±2.18 | 6.31±3.84 | 2.89±2.66 |
| ≥80 | 19 | 9.34±3.92 | 4.96±2.02 | 7.41±3.73 | 3.28±1.72 |
| Variance test F | 31.439 | 58.676 | 16.496 | 19.555 | |
| P | <0.001 | <0.001 | <0.001 | <0.001 | |
BMD: bone mineral density.
Associations between BMI1 and FRAX-based 10-year osteoporotic fracture probabilities.
| Without BMD | With BMD | ||||
|---|---|---|---|---|---|
| MOFP | HOFP | MOFP | HOFP | ||
| All subjects | r | -0.237 | -0.339 | -0.113 | -0.139 |
| P | <0.001 | <0.001 | 0.018 | 0.004 | |
| Males | r | -0.238 | -0.316 | -0.016 | -0.042 |
| P | 0.036 | 0.005 | 0.887 | 0.717 | |
| Females | r | -0.223 | -0.338 | -0.105 | -0.150 |
| P | <0.001 | <0.001 | 0.047 | 0.005 | |
Note: The result was derived based on partial correlation analysis after controlling for age;
BMI: body mass index;
BMD: bone mineral density;
MOFP: FRAX-based 10-year major osteoporotic fracture probability;
HOFP: FRAX-based 10-year hip osteoporotic fracture probability.
FRAX-based 10-year fracture probabilities among groups with different BMD1 levels in the risk stratification analysis.
| Stratum | Group | Without BMD | With BMD | ||
|---|---|---|---|---|---|
| Major fracture | Hip fracture | Major fracture | Hip fracture | ||
| Normal BMD based on FN | Normal BMD based on LS | 3.36 | 0.68 | 2.66 | 0.23 |
| Osteopenia based on LS | 4.31 | 0.98 | 3.14 | 0.25 | |
| Osteoporosis based on LS | 3.34 | 0.66 | 2.84 | 0.3 | |
| ANOVA F statistic | 1.75 | 1.326 | 1.431 | 0.827 | |
| P | 0.19 | 0.253 | 0.235 | 0.366 | |
| Osteopenia based on FN | Normal BMD based on LS | 4.51 | 1.48 | 4.17 | 1.13 |
| Osteopenia based on LS | 4.55 | 1.37 | 4.24 | 1.05 | |
| Osteoporosis based on LS | 4.87 | 1.36 | 4.92 | 1.24 | |
| ANOVA F statistic | 0.435 | 0.248 | 3.449 | 0.419 | |
| P | 0.51 | 0.619 | 0.065 | 0.518 | |
| Osteoporosis based on FN | Normal BMD based on LS | 6.07 | 2.15 | 7.7 | 3.03 |
| Osteopenia based on LS | 6.66 | 3.04 | 7.13 | 3.18 | |
| Osteoporosis based on LS | 6.7 | 2.86 | 8.46 | 3.78 | |
| ANOVA F statistic | 0.076 | 0.054 | 1.045 | 0.671 | |
| P | 0.783 | 0.816 | 0.309 | 0.414 | |
| Normal BMD based on LS | Normal BMD based on FN | 3.35 | 0.68 | 2.66 | 0.23 |
| Osteopenia based on FN | 4.51 | 1.48 | 4.17 | 1.13 | |
| Osteoporosis based on FN | 6.07 | 2.15 | 7.7 | 3.03 | |
| ANOVA F statistic | 9.039 | 16.187 | 40.152 | 62.962 | |
| P | 0.003 | <0.001 | <0.001 | <0.001 | |
| Osteopenia based on LS | Normal BMD based on FN | 4.31 | 0.98 | 3.14 | 0.25 |
| Osteopenia based on FN | 4.54 | 1.37 | 4.24 | 1.05 | |
| Osteoporosis based on FN | 6.66 | 3.04 | 7.13 | 3.18 | |
| ANOVA F statistic | 8.723 | 23.118 | 38.424 | 84.782 | |
| P | 0.004 | <0.001 | <0.001 | <0.001 | |
| Osteoporosis based on LS | Normal BMD based on FN | 3.34 | 0.66 | 2.84 | 0.3 |
| Osteopenia based on FN | 4.87 | 1.36 | 4.92 | 1.23 | |
| Osteoporosis based on FN | 6.7 | 2.86 | 8.46 | 3.78 | |
| ANOVA F statistic | 10.297 | 16.249 | 26.795 | 27.027 | |
| P | 0.002 | <0.001 | <0.001 | <0.001 | |
BMD: bone mineral density;
FN: femoral neck;
LS: lumbar spine.
Associations between FRAX-based 10-year fracture probabilities and BMD1 at different sites.
| Without BMD | With BMD | ||||
|---|---|---|---|---|---|
| MOFP | HOFP | MOFP | HOFP | ||
| FN BMD | r | -0.60 | -0.60 | -0.34 | -0.39 |
| P | <0.001 | <0.001 | <0.001 | <0.001 | |
| r | -0.52 | -0.54 | -0.27 | -0.34 | |
| P | <0.001 | <0.001 | <0.001 | <0.001 | |
| LS BMD | r | -0.21 | -0.21 | -0.34 | -0.30 |
| P | <0.001 | <0.001 | <0.001 | <0.001 | |
| r | -0.02 | 0.02 | -0.01 | 0.05 | |
| P | 0.615 | 0.663 | 0.897 | 0.265 | |
BMD: bone mineral density;
MOFP: FRAX-based 10-year major osteoporotic fracture probability;
HOFP: FRAX-based 10-year hip osteoporotic fracture probability;
the relative coefficient derived based on a partial correlation analysis controlling for LS BMD;
the relative coefficient derived based on a partial correlation analysis controlling for FN BMD.